Reshema Kemps-Polanco, Executive Vice President of Novartis Oncology U.S., is responsible for all commercial and medical operations covering the United States.
A strong believer in servant leadership, Kemps-Polanco is inspired by improving healthcare outcomes through therapies and services that deliver advancements in the standard of care, creating equal access to medicines and decreasing healthcare inequities.
Kemps-Polanco embraces the Novartis curious, inspired and unbossed culture that enables teams to reimagine medicine. Her extensive experience in leading diverse, inclusive, high-performing teams is why she was recognized by the Healthcare Businesswomen’s Association (HBA) as a Rising Star.
Prior to returning to Novartis in 2021, Kemps-Polanco held progressive US and global leadership roles at Johnson and Johnson where most recently she was President, Janssen Cardiovascular & Metabolism.
Kemps-Polanco earned an MBA from Rutgers University, a Master’s in Industrial/ Organizational Behavior from Louisiana Tech University and a Bachelor’s from the University of Louisiana at Monroe. She also proudly served her country as a member of the U.S. Army.